Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com/registration2.aspx
I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.
Undervalued Stocks on AMEX
Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.
In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on AMEX
Today’s data is for companies listed on the American Stock Exchange.
| Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # of Estimates |
|---|---|---|---|---|---|---|
| CQP | Cheniere Energy Partners LP | 2017 | 31.750000 | 36.6667 | USD | 3 |
| MAG | MAG Silver Corp | 2017 | 12.500000 | 25.0568 | CAD | 8 |
| TXMD | TherapeuticsMD Inc | 2017 | 4.340000 | 24.0000 | USD | 2 |
| PARR | Par Pacific Holdings Inc | 2017 | 17.090000 | 23.0000 | USD | 1 |
| REI | Ring Energy Inc | 2017 | 13.120000 | 20.0000 | USD | 2 |
| SAND | Sandstorm Gold Ltd | 2017 | 3.810000 | 8.1942 | CAD | 8 |
| CRHM | CRH Medical Corp | 2017 | 5.650000 | 10.5687 | CAD | 11 |
| MTNB | Matinas BioPharma Holdings Inc | 2017 | 2.270000 | 7.0000 | USD | 2 |
| ALO | Alio Gold Inc | 2017 | 5.550000 | 9.9636 | CAD | 11 |
| AST | Asterias Biotherapeutics Inc | 2017 | 3.150000 | 12.0000 | USD | 1 |
| DLA | Delta Apparel Inc | 2018 | 21.120000 | 26.0000 | USD | 1 |
| OCX | OncoCyte Corp | 2017 | 5.050000 | 12.0000 | USD | 1 |
| TIS | Orchids Paper Products Co | 2017 | 12.200000 | 22.0000 | USD | 1 |
| GDP | Goodrich Petroleum Corp | 2017 | 12.700000 | 23.0000 | USD | 1 |
| USAS | Americas Silver Corp | 2017 | 2.890000 | 11.1500 | CAD | 1 |
| UUUU | Energy Fuels Inc | 2017 | 1.530000 | 6.4690 | CAD | 1 |
| AINC | Ashford Inc | 2017 | 50.250000 | 56.0000 | USD | 1 |
| UFAB | Unique Fabricating Inc | 2017 | 9.970000 | 15.0000 | USD | 1 |
| VISI | Volt Information Sciences Inc | 2017 | 4.100000 | 14.0000 | USD | 1 |
| VNRX | VolitionRX Ltd | 2017 | 3.500000 | 8.5000 | USD | 2 |
| RNN | Rexahn Pharmaceuticals Inc | 2017 | 3.130000 | 19.5000 | USD | 1 |
| ATNM | Actinium Pharmaceuticals Inc | 2017 | 1.360000 | 8.0000 | USD | 1 |
| PTN | Palatin Technologies Inc | 2018 | 0.350000 | 6.0000 | USD | 1 |
| JOB | GEE Group Inc | 2018 | 5.325000 | 10.0000 | USD | 1 |
| CRMD | Cormedix Inc | 2017 | 0.425000 | 5.0000 | USD | 1 |
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
TXMD:ASE TherapeuticsMD
http://www.therapeuticsmd.com
TherapeuticsMD has 159 employees and is headquartered in United States.
TherapeuticsMD Inc is a women’s health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product.
PARR:ASE Par Pacific Holdings
http://www.parpacific.com
Par Pacific Holdings has 863 employees and is headquartered in United States.
Par Pacific Holdings Inc is an oil refining and marketing company. It owns and operates refineries with related logistics and retail networks. It also transports, markets and distributes crude oil.
Free Valuation
Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.